Please login to the form below

Not currently logged in
Email:
Password:

European bioinformatics institute appoints GSK's Dr Andrew Leach

He joins the EMBL-EBI as head of chemistry services

EMBL EBI Dr Andrew LeachThe European Bioinformatics Institute (EBI) has appointed Dr Andrew Leach as head of chemistry services, who will take up the position on 1 September.

Dr Leach moves to the institute - a part of the European Molecular Biology Laboratory (EMBL) - from GSK Research and Development, which he joined in 1994 as a research scientist and manager.

From there, Dr Leach progressed to director of computational chemistry, Europe before taking on his most recent role as head of biomolecular sciences in which he delivered biophysics, structural biology and bioanalytical data analysis and expertise.

Between 2006 and 2015, he served as a trustee of the Cambridge Crystallographic Data Centre and was editor of the Journal of Computer-Aided Molecular Design from 1997 to 2012.

Dr Rolf Apweiler, director of EMBL-EBI, said: “Dr Leach is greatly respected in the pharma world and brings with him a wealth of knowledge and experience in drug discovery and cheminformatics.

“As a user of EMBL-EBI resources throughout his career, Andrew brings unique insights into the pharma industry's user requirements and an exciting vision for future exploitation of opportunities in data, analytics and computation.”

Dr Leach said: “I am honoured to have been chosen to take on the leadership of EMBL-EBI's highly successful chemistry services.

“I know first-hand the huge value that EMBL-EBI's resources bring to bench scientists in the industry and am looking forward to taking EMBL-EBI's chemical biology data services to the next level.”

29th March 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics